Pazopanib in metastatic renal carcinoma (mRC): Experience of 31 centers in Spain in first, second, third, or subsequent lines in daily clinical practice.
Angel Rodriguez Sanchez
Honoraria - GlaxoSmithKline
Rocio García Domínguez
Honoraria - GlaxoSmithKline
Guillermo De Velasco
Honoraria - GlaxoSmithKline
Alvaro Pinto
No relevant relationships to disclose
Javier Puente
Honoraria - GlaxoSmithKline
Gustavo Rubio
Honoraria - GlaxoSmithKline
Sergio Vazquez-Estevez
Honoraria - GlaxoSmithKline
Marta Juan
No relevant relationships to disclose
Manuel Constenla
Honoraria - GlaxoSmithKline
Marta Lopez Brea
Honoraria - GlaxoSmithKline
Maria Sereno
Honoraria - GlaxoSmithKline
Javier L. Puertas
Honoraria - GlaxoSmithKline
Maria Garrido
Honoraria - GlaxoSmithKline
David Marrupe
Honoraria - GlaxoSmithKline
Maria L Villalobos
Honoraria - GlaxoSmithKline
Blanca Cantos
Honoraria - GlaxoSmithKline
Teresa de Portugal
Honoraria - GlaxoSmithKline
Rocio Vilchez
No relevant relationships to disclose
Jose-Luis Gonzalez-Larriba
Honoraria - GlaxoSmithKline
Jose Angel Arranz Arija
Honoraria - GlaxoSmithKline